Contact
searchSearch
HMP Global

Volume 26 - Issue 7 - July 2014

Pneumatosis Intestinalis, a Dreaded Complication of Intra-Aortic Balloon Pump Use
07/08/2014
Saurabh Rajpal, MD, MBBS; Nuri Ilker Akkus, MD
A patient is described who required IABP support and later developed a grim complication of pneumatosis intestinalis despite smaller-size IABP use. This complication should be taken into consideration in females with small size and diseased...
A patient is described who required IABP support and later developed a grim complication of pneumatosis intestinalis despite smaller-size IABP use. This complication should be taken into consideration in females with small size and diseased...
A patient is described who...
07/08/2014
Journal of Invasive Cardiology
Invasive Hepatocellular Carcinoma With Recurrent Pulmonary Embolism: Use of AngioVac CannulaThrombectomy Device for Mechanical Aspiration
07/08/2014
Sanjay K. Gandhi, MD, PhD; Prasanna Sengodan, MD; Harpreet Grewal, MD
We describe the use of a novel AngioVac venous extracorporeal bypass system (AngioDynamics) to remove a part of large right atrial tumor and thrombus in a patient with recurrent pulmonary embolism from hepatocellular carcinoma infiltrating...
We describe the use of a novel AngioVac venous extracorporeal bypass system (AngioDynamics) to remove a part of large right atrial tumor and thrombus in a patient with recurrent pulmonary embolism from hepatocellular carcinoma infiltrating...
We describe the use of a novel...
07/08/2014
Journal of Invasive Cardiology
Bioresorbable Vascular Scaffold Collapse Causes Subacute Thrombosis
07/08/2014
Rafael J. Ruiz-Salmeron, PhD; Sofía Pereira, MD; Daniela de Araujo, MD
We report a subacute bioresorbable scaffold thrombosis caused by stent collapse into a heavily calcified lesion.
We report a subacute bioresorbable scaffold thrombosis caused by stent collapse into a heavily calcified lesion.
We report a subacute...
07/08/2014
Journal of Invasive Cardiology
Double Balloon Aortic Valvuloplasty in TAVI Era: Insight From Intracardiac Echocardiography and Multidetector Computed Tomography Findings
07/08/2014
Taku Inohara, MD; Kentaro Hayashida, MD, PhD; Keiichi Fukuda, MD, PhD
We describe a case of severe aortic stenosis complicated with severe peripheral artery disease that was successfully treated with double-balloon aortic valvuloplasty using bilateral brachial access.
We describe a case of severe aortic stenosis complicated with severe peripheral artery disease that was successfully treated with double-balloon aortic valvuloplasty using bilateral brachial access.
We describe a case of severe...
07/08/2014
Journal of Invasive Cardiology
Transcatheter Closure of Left Pulmonary Artery to Left Atrium Fistula in a Neonate Using Amplatzer Duct Occluder I
07/08/2014
Abhishek Raval, MD; Nilesh Oswal, MD; Bhavesh M. Thakkar, MD, DM
The first case of successful transcatheter closure of a large left pulmonary artery to left atrial fistula with Amplatzer duct occluder in a cyanotic neonate by transseptal approach is described.
The first case of successful transcatheter closure of a large left pulmonary artery to left atrial fistula with Amplatzer duct occluder in a cyanotic neonate by transseptal approach is described.
The first case of successful...
07/08/2014
Journal of Invasive Cardiology
Single 6 Fr Transradial Guiding Catheter for Retrograde Recanalization of Left Coronary Artery Chronic Total Occlusions:‚Äà A Case Series
07/08/2014
Tak-Shun Chung, MD, MBBS; Pierfrancesco Agostoni, MD, PhD
A case series demonstrating that in selected anatomies it is possible, feasible, and safe to perform single 6 Fr transradial guiding catheter retrograde recanalization of left-sided CTO via ipsilateral epicardial or septal collateral...
A case series demonstrating that in selected anatomies it is possible, feasible, and safe to perform single 6 Fr transradial guiding catheter retrograde recanalization of left-sided CTO via ipsilateral epicardial or septal collateral...
A case series demonstrating that...
07/08/2014
Journal of Invasive Cardiology

Column

Radial Access Technique
Transradial Renal Denervation for the Treatment of Resistant Hypertension
07/08/2014
Haiying Wu, MD; Yuejin Yang, MD; Bo Xu, MBBS; Runlin Gao, MD; Hui Dong, MD; Xiongjing Jiang, MD; Tuo Liang, MD; Yubao Zou, MD, PhD; Ting Guan, BS ; Meng Peng, MD; Lei Song, MD, PhD; Huimin Zhang, MD
As a novel device-based approach targeting the renal sympathetic nerves, renal denervation has been shown to be effective and safe in reducing blood pressure. The femoral artery is currently the most common access site for this procedure due...
As a novel device-based approach targeting the renal sympathetic nerves, renal denervation has been shown to be effective and safe in reducing blood pressure. The femoral artery is currently the most common access site for this procedure due...
As a novel device-based approach...
07/08/2014
Journal of Invasive Cardiology

Feature

Clinical Images
IVUS-Guided High-Pressure Non-Compliant Balloon Dilation to Treat In-DES Restenosis
07/08/2014
George Kassimis, MD, PhD; Niket Patel, MBBS, BSc(Hons); Adrian P. Banning, MD, PhD, MBBS
A demonstration of the OPN NC balloon (Vascular Perspectives) dilating underexpanded stents after other NC balloons have failed. 
A demonstration of the OPN NC balloon (Vascular Perspectives) dilating underexpanded stents after other NC balloons have failed. 
A demonstration of the OPN NC...
07/08/2014
Journal of Invasive Cardiology
Original Contribution
Incidence and Predictors of Side-Branch Compromise in Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
07/08/2014
Tiong-Cheng Yeo, MD; Chi-Hang Lee, MD, MBBS, MRCP; Valerie Khoo; Liang Shen, PhD; Vanessa Khoo; Germaine Loo; Mark Richards, MD, PT
A study to determine the incidence and predictors of side-branch compromise in patients who underwent primary percutaneous coronary intervention for acute myocardial infarction.
A study to determine the incidence and predictors of side-branch compromise in patients who underwent primary percutaneous coronary intervention for acute myocardial infarction.
A study to determine the...
07/08/2014
Journal of Invasive Cardiology
Original Contribution
Outcomes With First- Versus Second-Generation Drug-Eluting Stents in Coronary Chronic Total Occlusions (CTOs): A Systematic Review and Meta-Analysis
07/08/2014
Jerrold M. Grodin, MD; Michael Luna, MD; Shuaib M. Abdullah, MD; Santiago Garcia, MD; Jeffrey L. Hastings, MD, MS; Anna P. Kotsia, MD, PhD; Viswanatha Lanka, MD; Georgios Christopoulos, MD; Vishal G. Patel, MD; Bilal Saeed, MD; Atif Mohammad, MD; Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI; Subhash Banerjee, MD, FSCAI; Bavana V. Rangan, BDS, MPH, MD
A systematic review and meta-analysis of studies reporting outcomes after first- and second-generation drug-eluting stent (DES) implantation in chronic total occlusions. 
A systematic review and meta-analysis of studies reporting outcomes after first- and second-generation drug-eluting stent (DES) implantation in chronic total occlusions. 
A systematic review and...
07/08/2014
Journal of Invasive Cardiology

News

Radiation Protection Systems
Rampart IC Secures Series B Financing to Fuel Strategic Growth and Expand Access to Radiation Safety Solutions
04/24/2025
Rampart IC, a medical technology company developing market-leading radiation safety and orthopedic protection solutions for the interventional suite, announced the successful completion of its $21.6M Series B financing round. The round was...
Rampart IC, a medical technology company developing market-leading radiation safety and orthopedic protection solutions for the interventional suite, announced the successful completion of its $21.6M Series B financing round. The round was...
Rampart IC, a medical technology...
04/24/2025
Cath Lab Digest
MEeting Update
SCAI Scientific Sessions 2025 Features Latest Clinical Innovations in Cardiology Care
04/24/2025
Whether you’re focused on clinical care, innovation, or training the next generation, there’s something here to support your clinical, research, and career goals,” said SCAI President James B. Hermiller, MD, MSCAI.  
Whether you’re focused on clinical care, innovation, or training the next generation, there’s something here to support your clinical, research, and career goals,” said SCAI President James B. Hermiller, MD, MSCAI.  
Whether you’re focused on...
04/24/2025
Cath Lab Digest
Scientific Statement
HRS and ACC Release Joint Scientific Statement on the Safety of Same-Day Discharge for Intracardiac Catheter Ablation Procedures
04/24/2025
This document draws on global clinical data and real-world evidence to evaluate the impact of a cardiac ablation SDD strategy on patient safety, access, operational efficiencies, and healthcare costs. It also outlines best practices based on...
This document draws on global clinical data and real-world evidence to evaluate the impact of a cardiac ablation SDD strategy on patient safety, access, operational efficiencies, and healthcare costs. It also outlines best practices based on...
This document draws on global...
04/24/2025
EP Lab Digest
(Reproduced with permission from NEJM AI, Lampert, 2025. Copyright 2025 Massachusetts Medical Society)
AI: HCM
AI Algorithm Can Help Identify High-Risk Heart Patients to Quickly Diagnose, Expedite, and Improve Care
04/24/2025
Using the model to analyze patients’ ECG results could allow cardiologists to prioritize the highest-risk patients to bring them in sooner for an appointment and treatment before symptoms begin or exacerbate.
Using the model to analyze patients’ ECG results could allow cardiologists to prioritize the highest-risk patients to bring them in sooner for an appointment and treatment before symptoms begin or exacerbate.
Using the model to analyze...
04/24/2025
Cath Lab Digest
News
The Heart Rhythm Society Announces Framework for Establishing Atrial Fibrillation Centers of Excellence and Key Operational Standards
04/23/2025
The Heart Rhythm Society (HRS) releases a framework outlining criteria for establishing an Atrial Fibrillation (AF) Center of Excellence (CoE) and key operational standards to provide multidisciplinary care for AF patients.
The Heart Rhythm Society (HRS) releases a framework outlining criteria for establishing an Atrial Fibrillation (AF) Center of Excellence (CoE) and key operational standards to provide multidisciplinary care for AF patients.
The Heart Rhythm Society (HRS)...
04/23/2025
EP Lab Digest
Peripheral Arterial Disease
Efemoral Medical Releases Positive Long-Term Results from EFEMORAL I
04/23/2025
EFEMORAL I is a first-in-human clinical trial evaluating the performance of the Efemoral Vascular Scaffold System (EVSS) for the treatment of patients suffering symptomatic peripheral arterial occlusive disease from atherosclerosis of the...
EFEMORAL I is a first-in-human clinical trial evaluating the performance of the Efemoral Vascular Scaffold System (EVSS) for the treatment of patients suffering symptomatic peripheral arterial occlusive disease from atherosclerosis of the...
EFEMORAL I is a first-in-human...
04/23/2025
Cath Lab Digest
Large-Bore Vascular Closure
Vivasure Medical Receives CE Mark Approval in Europe for PerQseal Elite Vascular Closure System
04/22/2025
The PerQseal® Elite vascular closure system is a sutureless and fully bioresorbable large-bore vessel closure device. The company plans to launch the product in select European markets this summer.
The PerQseal® Elite vascular closure system is a sutureless and fully bioresorbable large-bore vessel closure device. The company plans to launch the product in select European markets this summer.
The PerQseal® Elite vascular...
04/22/2025
Cath Lab Digest
Lower-extremity intervention
First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using R3 Vascular's Magnitude Drug-Eluting Bioresorbable Scaffold
04/22/2025
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its...
04/22/2025
Cath Lab Digest
Uncontrolled Hypertension
Orchestra BioMed Receives FDA Breakthrough Device Designation for Atrioventricular Interval Modulation (AVIM) Therapy.
04/22/2025
“Patients at higher risk for mortality and morbidity associated with high blood pressure are the core of the population we are actively enrolling in the BACKBEAT global pivotal study of hypertensive pacemaker-indicated patients in...
“Patients at higher risk for mortality and morbidity associated with high blood pressure are the core of the population we are actively enrolling in the BACKBEAT global pivotal study of hypertensive pacemaker-indicated patients in...
“Patients at higher risk for...
04/22/2025
Cath Lab Digest
Cardiomyopathy
FDA Updates Camzyos (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications
04/21/2025
Camzyos is an FDA-approved cardiac myosin inhibitor for the treatment of adults with symptomatic New York Heart Association (NYHA) Class II-III obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms.(1)
Camzyos is an FDA-approved cardiac myosin inhibitor for the treatment of adults with symptomatic New York Heart Association (NYHA) Class II-III obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms.(1)
Camzyos is an FDA-approved...
04/21/2025
Cath Lab Digest

Radiation Protection Systems
Rampart IC Secures Series B Financing to Fuel Strategic Growth and Expand Access to Radiation Safety Solutions
04/24/2025
Rampart IC, a medical technology company developing market-leading radiation safety and orthopedic protection solutions for the interventional suite, announced the successful completion of its $21.6M Series B financing round. The round was...
Rampart IC, a medical technology company developing market-leading radiation safety and orthopedic protection solutions for the interventional suite, announced the successful completion of its $21.6M Series B financing round. The round was...
Rampart IC, a medical technology...
04/24/2025
Cath Lab Digest
MEeting Update
SCAI Scientific Sessions 2025 Features Latest Clinical Innovations in Cardiology Care
04/24/2025
Whether you’re focused on clinical care, innovation, or training the next generation, there’s something here to support your clinical, research, and career goals,” said SCAI President James B. Hermiller, MD, MSCAI.  
Whether you’re focused on clinical care, innovation, or training the next generation, there’s something here to support your clinical, research, and career goals,” said SCAI President James B. Hermiller, MD, MSCAI.  
Whether you’re focused on...
04/24/2025
Cath Lab Digest
Scientific Statement
HRS and ACC Release Joint Scientific Statement on the Safety of Same-Day Discharge for Intracardiac Catheter Ablation Procedures
04/24/2025
This document draws on global clinical data and real-world evidence to evaluate the impact of a cardiac ablation SDD strategy on patient safety, access, operational efficiencies, and healthcare costs. It also outlines best practices based on...
This document draws on global clinical data and real-world evidence to evaluate the impact of a cardiac ablation SDD strategy on patient safety, access, operational efficiencies, and healthcare costs. It also outlines best practices based on...
This document draws on global...
04/24/2025
EP Lab Digest
Heart Disease Research
Link Between Heart Attack Severity and Circadian Rhythm Unveiled by UTHealth Houston Researchers
04/24/2025
“If you have a heart attack in the morning, you are more likely to have fatal arrhythmias, heart failure, and you’re more likely to die from it. The question we asked is ‘Why?’” said Holger Eltzschig, MD, PhD.
“If you have a heart attack in the morning, you are more likely to have fatal arrhythmias, heart failure, and you’re more likely to die from it. The question we asked is ‘Why?’” said Holger Eltzschig, MD, PhD.
“If you have a heart attack in...
04/24/2025
Cath Lab Digest
(Reproduced with permission from NEJM AI, Lampert, 2025. Copyright 2025 Massachusetts Medical Society)
AI: HCM
AI Algorithm Can Help Identify High-Risk Heart Patients to Quickly Diagnose, Expedite, and Improve Care
04/24/2025
Using the model to analyze patients’ ECG results could allow cardiologists to prioritize the highest-risk patients to bring them in sooner for an appointment and treatment before symptoms begin or exacerbate.
Using the model to analyze patients’ ECG results could allow cardiologists to prioritize the highest-risk patients to bring them in sooner for an appointment and treatment before symptoms begin or exacerbate.
Using the model to analyze...
04/24/2025
Cath Lab Digest
News
The Heart Rhythm Society Announces Framework for Establishing Atrial Fibrillation Centers of Excellence and Key Operational Standards
04/23/2025
The Heart Rhythm Society (HRS) releases a framework outlining criteria for establishing an Atrial Fibrillation (AF) Center of Excellence (CoE) and key operational standards to provide multidisciplinary care for AF patients.
The Heart Rhythm Society (HRS) releases a framework outlining criteria for establishing an Atrial Fibrillation (AF) Center of Excellence (CoE) and key operational standards to provide multidisciplinary care for AF patients.
The Heart Rhythm Society (HRS)...
04/23/2025
EP Lab Digest
Peripheral Arterial Disease
Efemoral Medical Releases Positive Long-Term Results from EFEMORAL I
04/23/2025
EFEMORAL I is a first-in-human clinical trial evaluating the performance of the Efemoral Vascular Scaffold System (EVSS) for the treatment of patients suffering symptomatic peripheral arterial occlusive disease from atherosclerosis of the...
EFEMORAL I is a first-in-human clinical trial evaluating the performance of the Efemoral Vascular Scaffold System (EVSS) for the treatment of patients suffering symptomatic peripheral arterial occlusive disease from atherosclerosis of the...
EFEMORAL I is a first-in-human...
04/23/2025
Cath Lab Digest
Large-Bore Vascular Closure
Vivasure Medical Receives CE Mark Approval in Europe for PerQseal Elite Vascular Closure System
04/22/2025
The PerQseal® Elite vascular closure system is a sutureless and fully bioresorbable large-bore vessel closure device. The company plans to launch the product in select European markets this summer.
The PerQseal® Elite vascular closure system is a sutureless and fully bioresorbable large-bore vessel closure device. The company plans to launch the product in select European markets this summer.
The PerQseal® Elite vascular...
04/22/2025
Cath Lab Digest
Lower-extremity intervention
First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using R3 Vascular's Magnitude Drug-Eluting Bioresorbable Scaffold
04/22/2025
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its...
04/22/2025
Cath Lab Digest
Uncontrolled Hypertension
Orchestra BioMed Receives FDA Breakthrough Device Designation for Atrioventricular Interval Modulation (AVIM) Therapy.
04/22/2025
“Patients at higher risk for mortality and morbidity associated with high blood pressure are the core of the population we are actively enrolling in the BACKBEAT global pivotal study of hypertensive pacemaker-indicated patients in...
“Patients at higher risk for mortality and morbidity associated with high blood pressure are the core of the population we are actively enrolling in the BACKBEAT global pivotal study of hypertensive pacemaker-indicated patients in...
“Patients at higher risk for...
04/22/2025
Cath Lab Digest

July 2014 Volume 26 Issue 7

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use